MedPath

Misoprostol for Second Trimester Pregnancy Termination

Phase 2
Completed
Conditions
Intra Uterine Fetal Death
Registration Number
NCT02669420
Lead Sponsor
Assiut University
Brief Summary

The majority of second-trimester pregnancy termination performed in the United States are performed surgically by dilation and evacuation. The frequency of induction of abortion increases as gestational age advances. In the late second trimester and early third trimester, induction is the primary method of termination in cases of fetal abnormalities. In many other countries, however, induction is the primary method of abortion throughout the second trimester

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
180
Inclusion Criteria
  • Pregnancy 13-24 weeks.
  • Women with indication for termination of the pregnancy due to intra uterine fetal death
Exclusion Criteria

-Pregnancy before 13 weeks.

  • Pregnancy beyond 24 weeks.
  • Women with scared uterus.
  • Known hypersensitivity for misoprostol.
  • Refusal of the woman to participate.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
mean duration from the initial misoprostol dose until complete fetal expulsion24 hours
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.